Discussion on the detection of latent iron deficiency and iron deficiency anemia in gynecological practice and data on treatment outcomes

Close metadata

OBJECTIVE

The aim of study was to analyze the detection of iron deficiency anemia (IDA) and latent iron deficiency (LID) in women with abnormal uterine bleeding against the background of uterine myoma uterus, endometrial hyperplasia and genital endometriosis and to study the effectiveness of therapy of patients with uterine bleeding and LID by the combined preparation Ferretab comp.

MATERIAL AND METHODS

The main reason of women’s referral to a medical institution was an abnormal uterine bleeding, therefore all the included in the investigation of patients with this complaint were classified according to the causes of bleeding: uterine myoma, endometrial hyperplasia or genital endometriosis. A local observational study in real clinical practice was carried out on 117 women with and without iron deficiency: 60 women with IDA, and 27 women with LID and 30 women in a comparison group. All women with IDA and LID were treated with iron fumarate/folic acid (Ferretab comp.). The effectiveness of therapy was assessed after 4 and 12 weeks according to dynamics of hemograms.

RESULTS

As a result of selection at the first stage 117 women aged 20 to 48 years old who fulfilled the inclusion/exclusion criteria were included in the study. Mean hemoglobin and ferritin levels in the study population in women with abnormal uterine bleeding, with bleeding on the background of uterine myoma, endometrial hyperplasia or endometriosis was 110.32±0.94 g/l for hemoglobin and 20.70±0.91 µg/l for ferritin. IDA was found in 51.3%, and LID in 23.1% of women without anemia but with iron deficiency. Blood counts of the comparison group of women (25.64%) were within normal limits. The mean hemoglobin and ferritin levels in the LID group increased after 4 weeks of therapy by 4 and 26.7% (p<0.001), while the 12-week therapy period it was 9 and 73.36% (p<0.001), respectively. Mean hemoglobin and ferritin levels in the IDA group after 4 weeks of therapy increased from the baseline by 9 and 66% (p<0.001) and after 12 weeks of therapy 23 and 288% (p<0.001) respectively. Therapy was continued in women in the IDA who didn’t reach target ferritin levels.

CONCLUSION

The use of Ferretab comp. is the drug of choice for patients with iron deficiency due to the presence of folic acid, which is a co-factor of iron, and also necessary for women of childbearing age, the dosage can be adjusted according to the patient’s needs and is well tolerated.

Keywords:

iron deficiency anemia

latent iron deficiency

iron fumarate

oral iron preparations

folic acid

uterine myoma

genital endometriosis

endometrial hyperplasia

Authors:

Kulikov I.A.

I.M. Sechenov First Moscow State Medical University;
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology

ORCID: 0000-0003-2499-4727

Gevorkyan G.A.

I.M. Sechenov First Moscow State Medical University;
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology

ORCID: 0000-0002-9788-2016

Received:

02.05.2023

Accepted:

06.05.2023

List of references:

Shmakov RG, Karimova GN. Anemia in pregnancy. M.: GEOTAR-Media; 2020;160. (In Russ.).
Drapkina OM, Martynov AI, Baida AP, Balan VE, Baranov II, Vlasova EE, Vorob’yov PA, Volkova SA, Gaiduk IYu, Gornostaeva ZhA, Grigor’eva NYu, Dobrokhotova YuE, Dvoretskii LI, Dikke GB, Dolgushina VF, Dunicheva OV, Eliseeva EV, Ivanova EV, Koryagina NA, Kunyaeva TA., Kupaev VI, Mitina TA, Mozheiko ME, Oboskalova TA, Orlova SV, Pestrikova TYu, Sanina NP, Sas EI, Safuanova GSh, Sokolova TM, Stuklov NI, Tov NL, Tribuntseva LV, Umarova ZA, Fatkullina LS, Fendrikova AV, Khlynova OV, Shavkuta GV, Sharapova YuA, Shikh EV, Shepel’ RN, Kaburova AN. Resolution of the expert council «Actual issues of iron deficiency in the Russian Federation». Kardiovaskulyarnaya terapiya i profilaktika. 2020;19:5:2700. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2700
Bolotova EV, Dudnikova AV, Krutova VA. The frequency and characteristics of iron deficiency in women of reproductive age. Klinicheskaya meditsina. 2020;98:4:287-293. (In Russ.). https://doi.org/10.30629/0023-2149-2020-98-4-287-293
Sakhin VT, Kryukov EV, Rukavitsyn OA. Anemia of chronic diseases. Ed. Kryukov E.V. M.: GEOTAR-Media; 2020;160. (In Russ.).
Vinogradova MA. Abnormal uterine bleeding. Hemostatic therapy: a hematologist’s view. Ginekologiya. 2022;24:2:157-162. (In Russ.). https://doi.org/10.26442/20795696.2022.2.201483
Zhorova VE. Therapy of iron deficiency anemia in gynecological patients. Meditsinskii sovet. 2019;7:148-152. (In Russ.). https://doi.org/10.21518/2079-701X-2019-7-148-152
Dobrokhotova YuE, Saprykin LV. Hyperplasia of the endometrium. 3rd ed., revised. and additional. M.: GEOTAR-Media; 2021;112. (In Russ.).
Vishnevskii AS. Hyperplastic syndrome in gynecology. 2nd ed. M.: GEOTAR-Media; 2018;192. (In Russ.).
Radzinskii VE, Orazov MR, Silant’eva ES, Orekhov RE, Khamoshina MB, Mullina IA, Tokaeva ES, Zakirova YaR, Bargesyan LK, Chitanava YuS. Endometriosis and pelvic pain. Ed. Orazov MR. M.: GEOTAR-Media; 2023;184. (In Russ.).
Endometriosis. Pathogenesis, diagnosis, treatment. Ed. Dubrovina S.O., Bezhenar’V.F. M.: GEOTAR-Media; 2020;352. (In Russ.).
Dobrokhotova YuE, Markova EA. New possibilities for the treatment of iron deficiency conditions in women in different age periods. RMZH. Mat’ i ditya. 2022;5:3:201-208. (In Russ.). https://doi.org/10.32364/2618-8430-2022-5-3-201-208
Dumanovskaya MR, Tabeeva GI, Ivannikova YuA, Solopova AE, Asaturova AV, Smetnik AA, Alieva PM, Ermakova EI, Pavlovich SV. Possibilities of modern pharmacotherapy of endometriosis. Akusherstvo i ginekologiya. 2023;2:38-45. https://doi.org/10.18565/aig.2022.293
Drug therapy of genital endometriosis: realities and prospects: a guide for doctors. Ed. Yarmolinskaya M.I. M.: GEOTAR-Media; 2021;384. (In Russ.).
Podzolkova NM, Korennaya VV, Koloda YuA. Uterine myoma. M.: GEOTAR-Media; 2015;160. (In Russ.).
Dobrokhotova YuE, Ibragimova DM, Saprykina LV. Uterine myoma. M.: GEOTAR-Media; 2018;96. (In Russ.).
Krasnopol’skaya KV, Kogan IYu. Uterine myoma and infertility: coping strategies: a guide for physicians. M.: GEOTAR-Media; 2021;144. (In Russ.).
Lukina EA, Ledina AV, Rogovskaya SI. Iron deficiency anemia: a view of a hematologist and gynecologist. We optimize diagnostics and treatment tactics. RMZH. Mat’ i ditya. 2020;3:4:248-253. (In Russ.). https://doi.org/10.32364/2618-8430-2020-3-4-248-253
Selikhova MS, Soltys PA, Kalacheva LS. Prevention and treatment of iron deficiency anemia in the practice of an obstetrician-gynecologist. RMZH. Mat’ i ditya. 2020;3:4:276-281. (In Russ.). https://doi.org/10.32364/2618-8430-2020-3-4-276-281
Shulaev AV, Chernobrovkina GI, Kuznetsova DR. Scientific substantiation of the cognitive-behavioral strategy for the prevention of iron deficiency in women of reproductive age. ORGZDRAV: novosti, mneniya, obucheniye. Vestnik VSHOUZ. 2021;7:4:32-39. (In Russ.). https://doi.org/10.33029/2411-8621-2021-7-4-32-39
Baranov II, Sal’nikova IA, Nesterova LA. Clinical guidelines for the diagnosis and treatment of iron deficiency conditions: a view from 2022. Akusherstvo i ginekologiya: novosti, mneniya, obucheniye. 2022;10:2:56-64. (In Russ.). https://doi.org/10.33029/2303-9698-2022-10-2-56-64
Gromova OA, Torshin IYu, Tetruashvili NK, Pavlovich SV. Systematic analysis of molecular synergism of folic acid and ferrous fumarate in iron deficiency anemia. Akusherstvo i ginekologiya. 2022;12:178-186. (In Russ.). https://doi.org/10.18565/aig.2022.301
Pavlovich SV. Algorithm for the treatment of iron deficiency in pregnant women. Akusherstvo i ginekologiya. 2022;9:15-20. (In Russ.).
Pavlovich SV, Melikhov OG, Khodzhaeva ZS, Muminova KT, Sakalo VA, Gorodnova EA, Abashova EI, Yarmolinskaya MI, Chulkov VS, Nazipova ZM, Savel’eva IV, Andreeva MD, Kudlai YuV, En’kova EV, Zaripova ASh. Results of a multicenter study of the effectiveness of a combined preparation containing ferrous fumarate and folic acid in anemia in the second trimester of pregnancy. Akusherstvo i ginekologiya. 2023;2:108-116. (In Russ.). https://doi.org/10.18565/aig.2023.51
Fedorova TA, Borzykina OM, Bakuridze EM, Ivanets TYu, Strel’nikova EV, Tsakhilova SG. Correction of iron deficiency anemia in patients with gynecological diseases using liposomal iron. Ginekologiya. 2017;19:1:68-72. (In Russ.).

Close metadata